Michael Untch
Works:
- Immunzytochemischer Nachweis von Tumorzellen im Knochenmark mittels monoklonaler Antikörper bei Mammakarzinompatientinnen zum Zeitpunkt der Primärtherapie
- Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
- Early modulation of circulating MicroRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
- ABC3 Consensus Commented from the Perspective of the German Guidelines : Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015